Delia Lanzillotta

Dr. Delia Lanzillotta

Department of Medicina Sperimentale e Clinica, University Magna Graecia, Campus "S. Venuta", 88100, Catanzaro, Italy.
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
SDSabrina D’aGostino
Sabrina D’aGostino
Delia LanzillottaDelia Lanzillotta
Delia Lanzillotta
MVMariaconcetta Varano
Mariaconcetta Varano
CBCirino Botta
Cirino Botta
ABAntonio Baldrini
Antonio Baldrini
TFTrapasso Francesco
Trapasso Francesco
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells

6 May 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Annalisa MarucaAnnalisa Maruca
Annalisa Maruca
Delia LanzillottaDelia Lanzillotta
Delia Lanzillotta
Roberta RoccaRoberta Rocca
Roberta Rocca
Antonio LupiaAntonio Lupia
Antonio Lupia
Giosuè CostaGiosuè Costa
Giosuè Costa
SAStefano Alcaro
Stefano Alcaro
Essential oils (EOs) are popular in aromatherapy, a branch of alternative medicine that claims their curative effects. Moreover, several studies reported EOs as potential anti-cancer agents by inducing apoptosis in different cancer cell models. In this study, we have considered EOs as a potential resource of new kinase inhibitors with a polypharmacological profile. On the other hand, computational methods offer the possibility to predict the theoretical activity profile of ligands, discovering dangerous off-targets and/or synergistic effects due to the potential multi-target action. With this aim, we performed a Structure-Based Virtual Screening (SBVS) against X-ray models of several protein kinases selected from the Protein Data Bank (PDB) by using a chemoinformatics database of EOs. By evaluating theoretical binding affinity, 13 molecules were detected among EOs as new potential kinase inhibitors with a multi-target profile. The two compounds with higher percentages in the EOs were studied more in depth by means Induced Fit Docking (IFD) protocol, in order to better predict their binding modes taking into account also structural changes in the receptor. Finally, given its good binding affinity towards five different kinases, cinnamyl cinnamate was biologically tested on different cell lines with the aim to verify the antiproliferative activity. Thus, this work represents a starting point for the optimization of the most promising EOs structure as kinase inhibitors with multi-target features.

25 November 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Annalisa MarucaAnnalisa Maruca
Annalisa Maruca
Roberta RoccaRoberta Rocca
Roberta Rocca
RCRaffaella Catalano
Raffaella Catalano
Francesco MesitiFrancesco Mesiti
Francesco Mesiti
Giosuè CostaGiosuè Costa
Giosuè Costa
Anna ArteseAnna Artese
Anna Artese
Mushrooms can be considered a valuable source of natural bioactive compounds with potential polypharmacological effects due to their proven antimicrobial, antiviral, antitumor, and antioxidant activities. In order to identify new potential anticancer compounds, an in-house chemical database of molecules extracted from both edible and non-edible fungal species was employed in a virtual screening against the isoform 7 of the Histone deacetylase (HDAC). This target is known to be implicated in different cancer processes, and in particular in both breast and ovarian tumors. In this work, we proposed the ibotenic acid as lead compound for the development of novel HDAC7 inhibitors, due to its antiproliferative activity in human breast cancer cells (MCF-7). These promising results represent the starting point for the discovery and the optimization of new HDAC7 inhibitors and highlight the interesting opportunity to apply the “drug repositioning” paradigm also to natural compounds deriving from mushrooms.

21 August 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
Giosuè CostaGiosuè Costa
Giosuè Costa
Annalisa MarucaAnnalisa Maruca
Annalisa Maruca
Roberta RoccaRoberta Rocca
Roberta Rocca
FAFrancesca Alessandra Ambrosio
Francesca Alessandra Ambrosio
Emanuela BerrinoEmanuela Berrino
Emanuela Berrino
Claudiu SupuranClaudiu Supuran
Claudiu Supuran
The tumor-associated isoenzymes hCA IX and hCA XII catalyze the hydration of carbon dioxide to bicarbonate and protons. These isoforms are highly overexpressed in many types of cancer, where they contribute to the acidification of the tumor environment, promoting tumor cell invasion and metastasis. In this work, in order to identify novel dual hCA IX and XII inhibitors, virtual screening techniques and biological assays were combined. A structure-based virtual screening towards hCA IX and XII was performed using a database of approximately 26,000 natural compounds. The best shared hits were submitted to a thermodynamic analysis and three promising best hits were identified and evaluated in terms of their hCA IX and XII inhibitor activity. In vitro biological assays were in line with the theoretical studies and revealed that syringin, lithospermic acid, and (-)-dehydrodiconiferyl alcohol behave as good hCA IX and hCA XII dual inhibitors.

9 April 2019 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
DNDonatella Nocera
Donatella Nocera
MMMiranda Menniti
Miranda Menniti
SBStefania Belviso
Stefania Belviso
HBHeather Bond
Heather Bond
Delia LanzillottaDelia Lanzillotta
Delia Lanzillotta
Rodolfo IulianoRodolfo Iuliano
Rodolfo Iuliano

4 July 2018 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
MSMarina Sala
Marina Sala
ASAntonia Spensiero
Antonia Spensiero
MSMaria Carmina Scala
Maria Carmina Scala
Giacomo PepeGiacomo Pepe
Giacomo Pepe
ABAnna Bilotta
Anna Bilotta
Pietro CampigliaPietro Campiglia
Pietro Campiglia